Physician profile
Brian Walcott
NPI 1093975500
$18,976.71
in general payments reported to CMS, 2019-2025
9 companies · $514 in 2025
The $514 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,676 · 2020: $9,609 · 2021: $884 · 2024: $294 · 2025: $514.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $808.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $808.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $9,765.14 | 2019-2020 | |
| Medical Device Business Services, INC. | $7,374.46 | 2019 | |
| Medtronic, INC. | $876.08 | 2021-2025 | Pipeline, Mazor X System |
| Microvention, INC. | $461.34 | 2019-2025 | Web Aneurysm Embolization System, Stent, Azur Cx Detachable |
| Zap Surgical Systems, INC. | $263.45 | 2021 | |
| Stryker Corporation | $140.72 | 2024 | Target, Surpass Evolve, Universal Neuro 3 |
| Penumbra, INC. | $45.06 | 2025 | Penumbra Coil 400 |
| Depuy Synthes Sales INC. | $27.57 | 2019 | |
| Abbott Laboratories | $22.89 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Walcott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.